Provided by Tiger Fintech (Singapore) Pte. Ltd.

Guardant Health Inc.

49.59
-0.4421-0.88%
Volume:26.27K
Turnover:1.32M
Market Cap:6.14B
PE:-14.68
High:50.30
Open:50.30
Low:49.59
Close:50.03
Loading ...

Guardant Health price target raised to $56 from $42 at TD Cowen

TipRanks
·
22 Feb

Guardant Health Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
22 Feb

BUZZ-Guardant Health sues Natera alleging trade secrets theft; shares of companies fall

Reuters
·
22 Feb

What's Going On With Cancer Diagnostic Firm Guardant Health On Friday?

Benzinga
·
22 Feb

Guardant Health sues rival Natera over cancer-testing trade secrets

Reuters
·
22 Feb

Guardant Health Price Target Raised to $59.00/Share From $39.00 by Raymond James

Dow Jones
·
22 Feb

UBS Adjusts Guardant Health Price Target to $65 From $40, Maintains Buy Rating

MT Newswires Live
·
21 Feb

Guardant Health Is Maintained at Overweight by JP Morgan

Dow Jones
·
21 Feb

Stock Track | Guardant Health Inc. Plummets 5.11% After Missing Earnings Estimates

Stock Track
·
21 Feb

Guardant Health Inc : UBS Raises Target Price to $65 From $40

THOMSON REUTERS
·
21 Feb

Stock Track | Guardant Health Inc. (GH) Soars 5.49% in Pre-Market on Strong Q4 Results and Promising Outlook

Stock Track
·
21 Feb

Guardant Health Inc : Canaccord Genuity Raises Target Price to $60 From $42

THOMSON REUTERS
·
21 Feb

Stifel Nicolaus Sticks to Its Buy Rating for Guardant Health (GH)

TIPRANKS
·
21 Feb

Guardant Health (GH) Receives a Buy from BTIG

TIPRANKS
·
21 Feb

Guardant Health price target raised to $56 from $49 at Guggenheim

TIPRANKS
·
21 Feb

CORRECTED-U.S. RESEARCH ROUNDUP-Blue Owl Capital, Insulet, Unity Software

Reuters
·
21 Feb

Guardant Health Inc (GH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com
·
21 Feb

Guardant Health Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
21 Feb

Guardant Health Inc : Leerink Partners Raises Target Price to $65 From $60

THOMSON REUTERS
·
21 Feb

AngloGold Ashanti delivers nine-fold increase in 2024 free cash flow* to $942m versus prior year; Adjusted EBITDA* +93% year-on-year and H2 dividend growth of 263% to 69 US cents per share; total cash costs* +4% for FY 2024, below group inflation

Business Wire
·
19 Feb